Comment on the potential utility of the new atypical antipsychotic lurasidone in the geriatric population
{{output}}
Lurasidone is the tenth atypical antipsychotic to be marketed in the United States. Like other atypical agents, lurasidone binds to a variety of central nervous system receptors, including dopamine (D2), norepinephrine (alpha 2A and 2C), and serotonin (1A, 2A,... ...
